"Cann currently has a five-year offtake agreement with Aurora that enables Cann to sell cannabis products to its former partner until 2024."
The agreement is still in place but with a heavy oversupply of cannabis product in the Americas ..... unlikely to be of any value.
Due to the balance sheet issues, it looks like Aurora was unable to put further money into CANN .... so perhaps we should be expecting further capital rasinings which is very disappointing to hear.
Certainly without the Department of Health making imported cannabis product meet quality standards in according to Pharmaceutical Inspection Co-operation Scheme (PIC/S) Good Manufacturing Practice (GMP) ....... CANN isn't looking like a great investment.
My stance remains Hold and Held. 4 days to go to NZ referendum which could lead to a bump in the price Monday. Then it's over to the Department of Health to save our investment along with the quality of medicinal products going into patients.
CAN Price at posting:
38.5¢ Sentiment: Hold Disclosure: Held
